These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 8566232)
1. The 3D-structure of a natural inhibitor of cell adhesion molecule expression. Hommel U; Weber HP; Oberer L; Naegeli HU; Oberhauser B; Foster CA FEBS Lett; 1996 Jan; 379(1):69-73. PubMed ID: 8566232 [TBL] [Abstract][Full Text] [Related]
2. NMR and X-ray crystallographic studies on cyclic tetrapeptide, cyclo (D-Phe-Pro-Sar-Gly). Jois DS; Suresh S; Vijayan M; Easwaran KR Int J Pept Protein Res; 1996 Jul; 48(1):12-20. PubMed ID: 8844259 [TBL] [Abstract][Full Text] [Related]
3. Crystal structure and NMR conformation of a cyclic pseudotetrapeptide containing urethane backbone linkages. Parkinson GN; Wu Y; Fan P; Kohn J; Baum J; Berman HM Biopolymers; 1994 Mar; 34(3):403-14. PubMed ID: 8161712 [TBL] [Abstract][Full Text] [Related]
4. Three-dimensional solution structure of mu-conotoxin GIIIB, a specific blocker of skeletal muscle sodium channels. Hill JM; Alewood PF; Craik DJ Biochemistry; 1996 Jul; 35(27):8824-35. PubMed ID: 8688418 [TBL] [Abstract][Full Text] [Related]
5. Solution, solid phase and computational structures of apicidin and its backbone-reduced analogs. Kranz M; Murray PJ; Taylor S; Upton RJ; Clegg W; Elsegood MR J Pept Sci; 2006 Jun; 12(6):383-8. PubMed ID: 16342331 [TBL] [Abstract][Full Text] [Related]
6. Solution structure and dynamics of G1TE, a nonphosphorylated cyclic peptide inhibitor for the Grb2 SH2 domain. Lou YC; Lung FD; Pai MT; Tzeng SR; Wei SY; Roller PP; Cheng JW Arch Biochem Biophys; 1999 Dec; 372(2):309-14. PubMed ID: 10600169 [TBL] [Abstract][Full Text] [Related]
7. Bicyclic peptides as type I/type II beta-turn scaffolds. Lombardi A; D'Auria G; Saviano M; Maglio O; Nastri F; Quartara L; Pedone C; Pavone V Biopolymers; 1996; 40(5):505-18. PubMed ID: 9062073 [TBL] [Abstract][Full Text] [Related]
8. 3D solution structure of copper and silver-substituted yeast metallothioneins. Peterson CW; Narula SS; Armitage IM FEBS Lett; 1996 Jan; 379(1):85-93. PubMed ID: 8566237 [TBL] [Abstract][Full Text] [Related]
9. Solution-phase parallel synthesis of a pharmacophore library of HUN-7293 analogues: a general chemical mutagenesis approach to defining structure-function properties of naturally occurring cyclic (depsi)peptides. Chen Y; Bilban M; Foster CA; Boger DL J Am Chem Soc; 2002 May; 124(19):5431-40. PubMed ID: 11996584 [TBL] [Abstract][Full Text] [Related]
10. Crystal and molecular structure of the depsipeptide ionophore hexadecaisoleucinomycin, cyclo-[(D-Ile-L-Lac-L-Ile-D-Hyi)4-] (C80H136N8O24). Pletnev VZ; Ivanov VT; Langs DA; Strong P; Duax WL Biopolymers; 1992 Jul; 32(7):819-27. PubMed ID: 1391633 [TBL] [Abstract][Full Text] [Related]
11. Solution and solid state structure of an aib-containing cyclodecapeptide inhibiting the cholate uptake in hepatocytes. Rossi F; Saviano M; Di Talia P; Di Blasio B; Pedone C; Zanotti G; Mosca M; Saviano G; Tancredi T; Ziegler K; Benedetti E Biopolymers; 1996; 40(5):465-78. PubMed ID: 9062069 [TBL] [Abstract][Full Text] [Related]
12. Multiple solution conformations of the integrin-binding cyclic pentapeptide cyclo(-Ser-D-Leu-Asp-Val-Pro-). Analysis of the (phi, psi) space available to cyclic pentapeptides. Viles JH; Mitchell JB; Gough SL; Doyle PM; Harris CJ; Sadler PJ; Thornton JM Eur J Biochem; 1996 Dec; 242(2):352-62. PubMed ID: 8973654 [TBL] [Abstract][Full Text] [Related]
13. Crystal structure and molecular conformation of the cyclic hexapeptide cyclo-(Gly-Aib-Gly)2. Escudero E; Vidal X; Solans X; Peggion E; Subirana JA J Pept Sci; 1996; 2(1):59-65. PubMed ID: 9225246 [TBL] [Abstract][Full Text] [Related]
14. Structure elucidation and 3D solution conformation of the antibiotic enduracidin determined by NMR spectroscopy and molecular dynamics. Castiglione F; Marazzi A; Meli M; Colombo G Magn Reson Chem; 2005 Aug; 43(8):603-10. PubMed ID: 15986494 [TBL] [Abstract][Full Text] [Related]
15. Molecular recognition: models for drug design. Breckenridge RJ Experientia; 1991 Dec; 47(11-12):1148-61. PubMed ID: 1765127 [TBL] [Abstract][Full Text] [Related]
16. Bioactive peptides: conformational studies of [Tyr4] cyclolinopeptide A. Saviano M; Rossi F; Filizola M; Isernia C; Di Blasio B; Benedetti E; Pedone C; Siemion IZ; Pedyczak A Biopolymers; 1995 Oct; 36(4):453-60. PubMed ID: 7578940 [TBL] [Abstract][Full Text] [Related]
17. Conformational mimicry: synthesis and solution conformation of a cyclic somatostatin hexapeptide containing a tetrazole cis amide bond surrogate. Beusen DD; Zabrocki J; Slomczynska U; Head RD; Kao JL; Marshall GR Biopolymers; 1995 Aug; 36(2):181-200. PubMed ID: 7492745 [TBL] [Abstract][Full Text] [Related]
18. Molecular dynamics simulation in vacuo and in solution of cyclolinopeptide A: a conformational study. Saviano M; Aida M; Corongiu G Biopolymers; 1991 Jul; 31(8):1017-24. PubMed ID: 1782353 [TBL] [Abstract][Full Text] [Related]
19. The crystal structure of an N-terminal two-domain fragment of vascular cell adhesion molecule 1 (VCAM-1): a cyclic peptide based on the domain 1 C-D loop can inhibit VCAM-1-alpha 4 integrin interaction. Wang JH; Pepinsky RB; Stehle T; Liu JH; Karpusas M; Browning B; Osborn L Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5714-8. PubMed ID: 7539925 [TBL] [Abstract][Full Text] [Related]
20. Structures of the contryphan family of cyclic peptides. Role of electrostatic interactions in cis-trans isomerism. Pallaghy PK; He W; Jimenez EC; Olivera BM; Norton RS Biochemistry; 2000 Oct; 39(42):12845-52. PubMed ID: 11041849 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]